Assessment of intestinal microbiota of full-term breast-fed infants from two different geographical locations by Peso Echarri, Patricia et al.
Assessment of intestinal microbiota of full-term breast-fed infants from 
two different geographical locations 
Running title: Microbiota in infants from different locations 
Patricia Peso Echarri1,2, Carmen Martínez Graciá2, Gaspar Ros Berruezo2, 
Inmaculada Vives3, Maria Ballesta3, Gonzalo Solís4,‡, Isabel Vasallo Morillas5, 
Clara G. de los Reyes-Gavilán1, Abelardo Margolles1 and Miguel Gueimonde1,* 
 
1Department of Microbiology and Biochemistry of Dairy Products, Institute of 
Diary Products of Asturias (IPLA-CSIC), Villaviciosa, Asturias, Spain 
2Department of Food Science and Nutrition. Veterinary Faculty. University of 
Murcia. Murcia, Spain. 
3Paediatrics Service, Virgen de la Arrixaca Hospital, Murcia, Spain.  
4Paediatrics Service, Hospital Cabueñes, Gijón, SESPA, Asturias, Spain. 
5Hero España S. A. Murcia, Spain. 
 
* Corresponding author: Miguel Gueimonde. Department of Microbiology and 
Biochemistry of Dairy Products. Instituto de Productos Lácteos de Asturias. 
CSIC. Ctra. Infiesto s/n, 33300 Villaviciosa, Asturias, Spain. Tel. +34 
985892131, Fax. +34 985892233. E-mail; mgueimonde@ipla.csic.es 
 
‡ Present address: Pediatrics Service, HUCA, Oviedo, SESPA, Asturias, Spain 
 
 
 
 
*4. Title page (with all author names, details and affiliations)
1 
 
Abstract 1 
The intestinal microbiota in the breast-fed infant is considered as ideally 2 
healthy. We assessed the microbiota of breast-fed full-term neonates from two 3 
different Spanish locations. Statistically significant geographical differences for 4 
different bacterial groups were found, underlining the need to consider and 5 
define geographical-related effects on microbiota. 6 
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Microbial colonization of the gut provides an essential stimulus for normal 26 
intestinal development and maturation of the immune system, contributing to 27 
the establishment of a proper intestinal homeostasis and mucosal barrier 28 
function [1]. Thus, early establishment of a healthy microbiota provides the first 29 
key step in the later well-being of the individual. Gut colonization begins with 30 
facultative anaerobes such as enterobacteria and lactobacilli and continues with 31 
anaerobic genera such as Bifidobacterium, Bacteroides, and Clostridium. 32 
Subsequently, feeding practices affect the population levels of different 33 
microbes [2,3]. Breast-milk is the ideal food in early life and it is known to play 34 
an important role in the establishment of the intestinal microbiota. The profile of 35 
fecal microbiota in the breast-fed infant is considered as ideally healthy. 36 
Therefore, promotion of a microbiota resembling that of the healthy breast-fed 37 
infant is often taken as a target for improving the functionality of infant formulas 38 
by using pro- and prebiotics.  39 
Recent reports have indicated the difficulty of defining the common phylogenetic 40 
core of the human healthy intestinal microbiota [4,5]. In infants, the microbiota 41 
of the healthy, breast-fed, vaginally delivered, full-term baby is considered the 42 
gold standard. However, although the influence of feeding habits, i.e. breast 43 
versus formula-fed, and mode of delivery have been extensively studied on the 44 
so defined “healthy infant microbiota”, the effect of other factors such as 45 
geographical origin have been addressed in a limited number of studies [6]. 46 
The aim of this study was to assess the intestinal microbiota of exclusively 47 
breast-fed neonates from two different geographical Spanish locations.  48 
Forty healthy full-term exclusively breast-fed infants, born either at the 49 
Neonatology Unit of Cabueñes Hospital from Asturias (20 infants; 11 males/9 50 
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females) or at the Neonatology Unit of the University Hospital  Virgen de la 51 
Arrixaca from Murcia (20 infants; 12 males/ 8 females), after an uncomplicated 52 
pregnancy were recruited. Infants were vaginally delivered, at a gestational age 53 
of 39.2 weeks (95%CI: 38.6-39.7) for Asturian infants and 39.1 (95% CI: 38.5-54 
39.7) weeks for those from Murcia. Birth weights ranged between 3238 and 55 
3586 grams (95% CI) in Asturias and between 3090 and 3411 grams (95% CI) 56 
in infants from Murcia. Microbiota of fecal samples collected at 8, 30 and 90 57 
days of life were compared to ascertain the possible effect of geographical 58 
origin of samples. Fecal samples were immediately cooled to 4oC after 59 
collection, delivered to the laboratory within 4 h, and frozen at –75oC directly on 60 
receipt until analysis. None of the mothers or babies received antibiotic therapy 61 
during the sampling period. The study was approved by the Regional 62 
Committees on Clinical Research from Asturias and Murcia regions. All parents 63 
gave written informed consent to participate in the study. 64 
Fecal DNA, as well as DNA from bacterial cultures used for calibration curves, 65 
was extracted as previously described [7] by using the QIAamp DNA stool mini 66 
kit (Qiagen, Hilden, Germany). Quantification of the different bacterial 67 
populations in feces was performed by quantitative PCR using primers shown in 68 
Table 1. All reactions were performed in a 7500 Fast Real Time PCR System 69 
(Applied Biosystems, Foster City, CA) using the SYBR Green PCR Master Mix 70 
(Applied Biosystems). 1 µL (~5ng) of template fecal DNA and 0.2 µM of each 71 
primer were used in the 25 µL PCR reaction. Thermal cycling consisted of an 72 
initial cycle of 95oC 10 min followed by 40 cycles of 95oC 15 s and 1 min at the 73 
appropriate temperature (Table 1). In the negative samples the value of the 74 
detection limits obtained for the corresponding primer pair was assigned. 75 
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Standard curves were made with pure cultures of appropriate strains (Table 1) 76 
which were grown overnight in GAM medium (Nissui Pharmaceutical Co, Tokio, 77 
Japan) under anaerobic conditions. Samples were analyzed by duplicate in at 78 
least two independent PCR runs.  79 
No differences in background parameters (birth weight, gestational age) were 80 
observed between both study groups. A high inter-individual variability was 81 
observed on the levels of the different microbial groups. However, despite this 82 
variability our results showed statistically significant (U-test; p<0.05) higher 83 
levels of Bacteroides (8.30±1.90 vs. 6.90±1.86 Log no. cells g-1) and 84 
Staphylococcus (6.64±1.08 vs. 5.62±1.01) at 8 days of age and lower of 85 
Enterobacteriaceae (9.17±0.84 vs. 9.90±0.65) at 90 days of life in infants from 86 
Murcia than in those from Asturias (Figure 1). Similar levels of 87 
Enterococcaceae, Clostridia XIVa and IV groups, Atopobium, Bifidobacterium 88 
and Lactobacillus were found between both groups (Figure 1). When all the 89 
sampling points were taken together, a trend (p=0.08) to lower counts of 90 
lactobacilli and higher of C. leptum group (p=0.06), as well as significantly 91 
higher levels of Bacteriodes and Staphylococcus were observed in Murcian 92 
infants as compared to those from Asturias (data not shown). Interestingly, at 93 
qualitative level C. leptum was more frequently detected in newborns from 94 
Asturias than in those from Murcia (64 vs. 25% of infants at 8 days, 77 vs. 55% 95 
at 30 days and 92 vs. 65% at 3 months of age; Fisher’s exact test, p<0.05) 96 
whilst no statistically significant differences were obtained in the occurrences of 97 
the other microbial groups tested. 98 
In both populations a significant negative correlation was observed between the 99 
levels of Bacteriodes and those of Enterococcaceae (Pearson’s correlation 100 
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coefficients, -0.208 and -0.268 for Asturias and Murcia infants, respectively, 101 
p<0.05 for both cases) whilst Bacteriodes levels correlate positively with those 102 
of Bifidobacterium (Asturias 0.319; Murcia 0.409, p<0.05 for both cases). 103 
Similarly significant positive correlations (p<0.05) were observed in both groups 104 
of infants between levels of Enterococcaceae and Enterobacteriaceae (0.473 105 
and 0.276 for Asturias and Murcia, respectively), between C. leptum and C. 106 
coccoides groups (Asturias 0.234; Murcia 0.360) and between bifidobacterial 107 
levels and those of lactobacilli (0.368 and 0.258) or Atopobium (0.412 and 108 
0.213 for Asturias and Murcia, respectively). Interestingly, a very significant 109 
positive correlation between Bacteriodes and Atopobium was observed in 110 
Asturian infants (0.662, p<0.05) but not in those from Murcia, whilst the contrary 111 
happened between Atopobium and C. coccoides (0.467, p<0.05 in infants from 112 
Murcia). 113 
When analysing samples from healthy children and adults, Lay and coworkers 114 
[8] did not found any geographical differences on microbiota composition. 115 
Contrary to this, when assessing the microbiota of adults and elderly from four 116 
European countries, quantitative country-specific differences were reported [9]. 117 
Moreover, a recent study [6] indicated differences on the gut microbiota 118 
composition of 6-weeks-old babies from five European countries. Interestingly, 119 
the study by Fallani and co-workers [6] observed, among others, higher levels 120 
of Bacteroides in 6-week-old infants from Granada (southern Spain) than in 121 
those from other more septentrional European locations. Similarly, in our study 122 
exclusively breast-fed, full-term, vaginally delivered infants from Murcia 123 
(southern Spain) presented higher levels of Bacteroides than those from 124 
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Asturias (northern Spain), indicating that this characteristic may be specific from 125 
the south of Spain. 126 
In spite of the high inter-individual variability our results evidenced some 127 
statistically significant differences between two cohorts of exclusively breast-fed 128 
full-term healthy Spanish neonates born in two different locations (~1000 km far 129 
from each other), one in the northern Atlantic coast and the other in the south-130 
east Mediterranean coast. All the infants were born at two hospitals of the 131 
Public Health System, where facilities and procedures are expected to be 132 
similar and therefore the two groups under study are likely to be quite 133 
homogeneous. Therefore, it is not surprising that the observed differences were 134 
limited to certain microbial populations whilst most of them showed a high 135 
similarity between both infant groups. In agreement with this, the correlations 136 
among the levels of the different bacteria analysed seem to be very consistent 137 
between both infant groups, although some specific correlations were observed 138 
to be different between them. This indicates that not only minor differences in 139 
composition are present between both infant groups, but also some interactions 140 
among the intestinal microorganisms present may differ depending on the 141 
geographical origin. 142 
Despite the differences observed in their microbiota, our two individual cohorts 143 
represent healthy breast-fed infants. Our study does not allow establishing firm 144 
conclusions about the factors explaining these microbiota differences, both 145 
locations are similar in terms of number of inhabitants and per capita income, 146 
but dietary habits are known to differ between them which is likely to have an 147 
influence. Our findings underline the difficulty of defining the healthy intestinal 148 
microbiota and suggest that factors related to geographical origin or dietary 149 
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background, likely through modulation of breast-milk composition [10], should 150 
be also taken into consideration. To this regard, a healthy intestinal microbiota 151 
could be defined as the intestinal microbial community that assist the host to 152 
maintain a healthy status under certain environmental conditions. This 153 
emphasizes that under specific environmental conditions the intestinal 154 
microbiota may contribute to health but the same composition under different 155 
conditions may lead to disease as suggested by the role that intestinal 156 
microbiota seems to play in obesity [11]. 157 
Although small, geographical or dietary differences in gut microbiota as those 158 
reported here may also have a deep impact on pro/prebiotics research. 159 
Interestingly, pioneer studies carried out in Finland demonstrated that atopic 160 
diseases can be prevented by administration of probiotics [12]. However, a 161 
study carried out in Germany following the same design and using the same 162 
probiotic strain found no effect [13]. Unfortunately background microbiotas were 163 
not compared. If, similarly to our infants, differences in background microbiota 164 
exist, they are likely to modify the effect of probiotics on microbiota composition, 165 
which may affect the clinical outcome of probiotic/prebiotic intervention studies. 166 
It has been previously indicated that a careful characterization of the intestinal 167 
microbiota in the target population should constitute the basis for probiotic and 168 
prebiotic use [14]. Our results stress this observation and underline the need to 169 
define the microbial core of the healthy infant microbiota taking into account the 170 
possible differences due to geographical origin. 171 
 172 
Acknowledgements 173 
8 
 
This work was funded by a CSIC intramural project (Ref. 200870I049) and the 174 
Spanish Plan Nacional de I+D+i  throught projects Consolider Ingenio 2010 175 
Programme (ref. FUN-C-FOOD CSD2007-0623) and AGL-2007-63504. P. 176 
Peso-Echarri was the recipient of a Fundación Seneca fellowship 177 
(07877/BPS/07). 178 
 179 
Conflict of interest statement 180 
All authors disclose any conflict of interest. 181 
 182 
References 183 
1 Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis 184 
with the intestinal microbiota. Nat Rev Immunol 2010;10:159-169. 185 
 2 Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. 186 
Factors influencing the composition of the intestinal microbiota in early 187 
infancy. Pediatrics 2006;118:511-521. 188 
3 De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massard S, 189 
et al. Impact of diet in shaping gut microbiota revealed by a comparative 190 
study in children from Europe and rural Africa. Proc Natl Acad Sci USA 191 
2010;107:14691-14696. 192 
4 Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, et al. Towards 193 
the human intestinal microbiota phylogenetic core. Environ Microbiol 194 
2009;11:2574-2584. 195 
5 Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, et 196 
al. A human gut microbial gene catalogue established by metagenomic 197 
sequencing. Nature 2010;464:59-67. 198 
9 
 
6 Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, et al. Intestinal 199 
microbiota of 6-week-old infants across Europe: Geographic influence 200 
beyond delivery mode, breast-feeding and antibiotics. J Pediatric 201 
Gastroenterol Nutr 2010;51:77-84. 202 
7 Gueimonde M, Tölkko S, Korpimäki T, Salminen S.  New real-time 203 
quantitative PCR procedure for quantification of bifidobacteria in human fecal 204 
samples. Appl Environ Microbiol 2004;70:4165-4169.  205 
8 Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan EE, de Vos WM, et 206 
al. Colonic microbiota signatures across five northern european countries. 207 
Appl Environ Microbiol 2005;71:4153-4155. 208 
9 Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, et al.. 209 
Differences in fecal microbiota in different European study populations in 210 
relation to age, gender and country: a cross-sectional study. Appl Environ 211 
Microbiol 2006;72:1027-1073. 212 
10 Nasser R, Stephen AM, Goh YK, Clandinin MT. The effect of a controlled 213 
manipulation of maternal dietary fat intake on medium and long chain fatty 214 
acids in human breast milk in Saskatoon, Canada. Int Breasfeed J 2010;5:3. 215 
11 Ley RE: Obesity and the human microbiome. Curr Opin Gastroenterol 216 
2010;26:5-11. 217 
12 Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. 218 
Probiotics in primary prevention of atopic disease: a randomised placebo-219 
controlled trial. Lancet 2001;357:1076-1079. 220 
13 Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-221 
blind, placebo controlled trial of probiotics for primary prevention: no clinical 222 
10 
 
effects of Lactobacillus GG supplementation. Pediatrics 2008;121:e850-223 
e856. 224 
14 Isolauri E, Salminen S. Probiotics: use in allergic disorders. A Nutrition, 225 
Allergy, Mucosal immunology and Intestinal microbiota (NAMI) research 226 
group report. J Clin Gastroenterol 2008;42:S91-S96. 227 
15 Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA 228 
gene-targeted group-specific primers for real-time PCR analysis of 229 
predominant bacteria in human feces. Appl Environ Microbiol 2004;70:7220-230 
7228. 231 
16 Layton A, McKay L, Williams D, Garrett V, Gentry R, Sayler G. Development 232 
of Bacteroides 16S rRNA gene TaqMan-based real-time PCR assays for 233 
estimation of total, human, and bovine fecal pollution in water. Appl Environ 234 
Microbiol 2006;72:4214-4224.  235 
17 Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of 236 
inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis 237 
and Faecalibacterium prausnitzii. Brit J Nutr 2009;101:541-550. 238 
18 Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an 239 
extensive set of 16S rDNA-targeted primers for quantification of pathogenic and 240 
indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 241 
2004;97:1166-1177. 242 
19 Matsuda K, Tsuji H, Asahara T, Kado Y, Nomoto K. Sensitive quantitative 243 
detection of commensal bacteria by rRNA-targeted reverse transcription-244 
PCR. Appl Environ Microbiol 2007;73:32-39. Erratum in: Appl Environ 245 
Microbiol 2007;73:6695. 246 
 247 
11 
 
 248 
12 
 
Table 1. Bacterial groups, standard cultures, primers and annealing temperatures used in this study 
 
Microbial target Strain used for standard curve Primer Sequence 5’-3’ Tm Ref 
Atopobium group 
Atopobium- Collinsella 
Collinsella intestinalis DSMZ13280 F: GGGTTGAGAGACCGACC 
R: CGGRGCTTCTTCTGCAGG 
55ºC [15] 
[15] 
Bacteroides group 
Bacteriodes-Prevotella-
Porphiromonas 
Bacteriodes thetaiotaomicron 
DSMZ2079 
F: GAGAGGAAGGTCCCCCAC 
R: CGCKACTTGGCTGGTTCAG 
60ºC [16] 
[17] 
Bifidobacterium Bifidobacterium longum 
NCIMB8809 
F: GATTCTGGCTCAGGATGAACGC 
R: CTGATAGGACGCGACCCCAT 
60ªC [5] 
[5] 
Clostridia XIVa group 
C.coccoides-E. rectale 
Clostridium coccoides DSMZ935 F: CGGTACCTGACTAAGAAGC 
R: AGTTTYATTCTTGCGAACG 
55ºC [18] 
[18] 
Clostridia IV 
C. leptum-F. praustnitzii 
Clostridium leptum DSMZ753 F: TTAACACAATAAGTWATCCACCTGG 
R: ACCTTCCTCCGTTTTGTCAAC 
60ºC [17] 
[17] 
Enterobacteriaceae Escherichia coli LMG2092 F: TGCCGTAACTTCGGGAGAAGGCA 
R: TCAAGGACCAGTGTTCAGTGTC 
60ºC [19] 
[19] 
Enterococcaceae Enterococcus faecalis IPLAIF3/1 F: CCCATCAGAAGGGGATAACACTT 
R: ACCGCGGGTCCATCCATC 
60ºC [19] 
[19] 
Lactobacillus Group Lactobacillus gasseri IPLAIF7/5 F: AGCAGTAGGGAATCTTCCA 
R: CATGGAGTTCCACTGTCCTC 
60ºC [18] 
This study 
Staphylococcus Staphylococcus epidermidis 
IPLAIF1/6 
F: ACGGTCTTGCTGTCACTTATA 
R: TACACATATGTTCTTCCCTAATAA 
60ºC [19] 
[19] 
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Figure 1. Bacterial levels, at the different sampling times, determined by qPCR 
in feces of breast-fed infants from two Spanish locations (about 1000 km apart 
from each other); Asturias (black diamonds) or Murcia (open squares). 
Asterisks indicate statistically significant differences between both groups at the 
corresponding sampling time (p<0.05). 
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